Study of Infections in Breast Augmentation Surgery with Implants in 9,691 Patients over 5 Years.
[BACKGROUND] This study presents a review of a single retrospective cohort of patients who underwent surgery for breast augmentation with implants, during a period of 5 years, aged 17-60 years (mean 3
- 95% CI 0.66-2.3
- 연구 설계 cohort study
APA
Mesa F, Cataño S, Tuberquia O (2021). Study of Infections in Breast Augmentation Surgery with Implants in 9,691 Patients over 5 Years.. Plastic and reconstructive surgery. Global open, 9(8), e3752. https://doi.org/10.1097/GOX.0000000000003752
MLA
Mesa F, et al.. "Study of Infections in Breast Augmentation Surgery with Implants in 9,691 Patients over 5 Years.." Plastic and reconstructive surgery. Global open, vol. 9, no. 8, 2021, pp. e3752.
PMID
34386312
Abstract
[BACKGROUND] This study presents a review of a single retrospective cohort of patients who underwent surgery for breast augmentation with implants, during a period of 5 years, aged 17-60 years (mean 32 years), in a single institution, IQ Interquirofanos, a private clinic in the city of Medellín, Colombia.
[METHOD] A single retrospective cohort study was carried out, in which the database of patients who underwent breast augmentation with implants during 5 years was analyzed.
[RESULTS] In this period of time, 9,691 female patients and a total of 19,382 breast implants implanted by 66 plastic surgeons underwent breast augmentation surgery. All the breast prostheses used were round, made of silicone gel in all cases and textured in most of them. 37 patients presented infection at the surgical site, 33 were unilateral and four bilateral, with an incidence of 0.38% per patient. The form of presentation was cellulitis in 46% of the cases, followed by seroma and hematoma in 25%. It was found that there is no difference in the incidence of infection between patients with breast augmentation for the first time and implant replacement due to different causes (OR 1.25, 95% CI 0.66-2.3, = 0.49). One of the surgeons was associated with 37.8% of the infections and was found to be an asymptomatic carrier of , requiring medical treatment. The relationship of the infection with the treating surgeons was also analyzed and it was found that there is an association between these two variables. The infection appeared in the first 2 weeks after surgery in 92.7% of the cases. The main isolated germ was , followed by , , , , , and a patient with in both breasts. Of the 37 patients with infection, six breast implants were required to be explanted in five patients, who were repositioned 3-6 months later without complications.
[CONCLUSIONS] Incidence of infection in augmentation mammoplasty with implants was 0.38% in patients infected in one or both breasts, during 5 years. There is a relationship between the presence of breast infection and the surgeon who performed the intervention. The most frequent germs found in breast implant infections continue to be followed by .
[METHOD] A single retrospective cohort study was carried out, in which the database of patients who underwent breast augmentation with implants during 5 years was analyzed.
[RESULTS] In this period of time, 9,691 female patients and a total of 19,382 breast implants implanted by 66 plastic surgeons underwent breast augmentation surgery. All the breast prostheses used were round, made of silicone gel in all cases and textured in most of them. 37 patients presented infection at the surgical site, 33 were unilateral and four bilateral, with an incidence of 0.38% per patient. The form of presentation was cellulitis in 46% of the cases, followed by seroma and hematoma in 25%. It was found that there is no difference in the incidence of infection between patients with breast augmentation for the first time and implant replacement due to different causes (OR 1.25, 95% CI 0.66-2.3, = 0.49). One of the surgeons was associated with 37.8% of the infections and was found to be an asymptomatic carrier of , requiring medical treatment. The relationship of the infection with the treating surgeons was also analyzed and it was found that there is an association between these two variables. The infection appeared in the first 2 weeks after surgery in 92.7% of the cases. The main isolated germ was , followed by , , , , , and a patient with in both breasts. Of the 37 patients with infection, six breast implants were required to be explanted in five patients, who were repositioned 3-6 months later without complications.
[CONCLUSIONS] Incidence of infection in augmentation mammoplasty with implants was 0.38% in patients infected in one or both breasts, during 5 years. There is a relationship between the presence of breast infection and the surgeon who performed the intervention. The most frequent germs found in breast implant infections continue to be followed by .
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 10 | |
| 합병증 | infection
|
감염 | dict | 7 | |
| 시술 | breast augmentation
|
유방성형술 | dict | 5 | |
| 시술 | augmentation mammoplasty
|
유방성형술 | dict | 1 | |
| 해부 | breasts
|
scispacy | 1 | ||
| 합병증 | hematoma
|
혈종 | dict | 1 | |
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | cellulitis
|
감염 | dict | 1 | |
| 약물 | silicone
|
C0037114
silicones
|
scispacy | 1 | |
| 질환 | Infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 질환 | breast infection
|
C0392317
Breast infection
|
scispacy | 1 | |
| 질환 | breast implant infections
|
scispacy | 1 | ||
| 질환 | breast prostheses
|
scispacy | 1 | ||
| 질환 | germ
|
scispacy | 1 | ||
| 질환 | breasts
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.